Article Information
History
- August 11, 2020.
Article Versions
- Version 1 (July 21, 2020 - 12:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- C Kelly2,3,*,
- R Gurung4,
- W Tinago1,
- R Kamngona2,
- I Sheha2,
- M Chammudzi2,
- K Jambo2,5,
- J Mallewa6,
- A Rapala7,
- RS Heyderman8,
- PWG Mallon1,
- H Mwandumba2,5,
- S Khoo3 and
- N Klein4
- 1Cente for Experimental Pathogen Host Research (CEPHR), University College Dublin, Ireland
- 2Malawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi
- 3Institute of Translational Medicine, University of Liverpool, UK
- 4Institute of Child Health, University College London, UK
- 5Liverpool School of Tropical Medicine, Liverpool, UK
- 6College of Medicine, University of Malawi, Malawi
- 7Institute of Cardiovascular Science, University College London, UK
- 8Division of Infection and Immunity, University College London
- ↵*Corresponding author:
Dr. Christine Kelly. Nelson Street, Dublin 7, Ireland. T +353 1 7164552, christine.kelly{at}ucd.ie
Posted August 11, 2020.
Circulating Microparticles are increased amongst people presenting with HIV and advanced immune suppression in Malawi and correlate closely with arterial stiffness
